PC04 - CMA Training Course

Sunday, October 30, 2022

9:00 AM – 5:00 PM

Location: Holiday 2-3, Level 2

CE: 7.5

Pre-Conference Speaker(s)

Yngvild Olsen, MD, MPH

Center Director
SAMHSA/CSAT
Rockville, Maryland
PJ

Patti Juliana, PhD

Director
Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration
Arthur McFarlane, II, MS

CEO
McFarlane and Associates LLC
Kalaheo, Hawaii
SM

Steve Millette, MS

Executive Director
Behavioral Health and Recovery at Gloo
Boulder, Colorado
David Whitesock, JD, MA

CEO / Founder
Commonly Well
Potsdam, New York

Download Slides
Anita R. Kennedy, BS CRPA CMA

Outreach Coordinator/Peer Engagement Specialist
Mount Sinai Beth Israel OTP
Jamaica, New York
Zachary C. Talbott, MSW

President
Talbott Legacy Centers | President, NAMA Recovery
Maryville, Tennessee

Learning Objectives:

At the completion of this activity, participants will:

Explain the use of medications to treat opioid use disorders and the laws and regulations that support medication assisted treatment in federally certified opioid treatment programs.
Describe the fundamental role of advocacy in supporting patients in medication assisted treatment programs, their families and their communities.
Identify at least one measurable outcome that significantly impacts an individuals access to success in recovery.

Presentation Summary: This training is designed for non-clinicians and provides a basic understanding of the physiology of opioid use disorder and the use of medications to treat it (i.e. methadone and buprenorphine). The course includes: basic clinical information about treatment with methadone, buprenorphine and naltrexone; a review of current regulations provided by regulatory authorities; basic communication skills and strategies to work as an advocate on such issues as educating patients about their rights, handling grievances, common legal issues, systems advocacy work and working within communities to benefit patients and treatment; the ethics of advocacy and; the mechanism of certification and how it professionalizes those committed to advocacy. Participants will come away with the initial tools for basic advocacy to grow and develop into successful advocates. This course fulfills the 8 hour training requirement for certification as a Medication Assisted Treatment Advocate (CMA). Candidates for certification must register with NAMA Recovery prior to the training. There is a registration fee of $100.00 that includes all materials, membership in NAMA Recovery, and the application for CMA. To register, please visit the NAMA Recovery Website.